Insight
Elisa Agostinetto
Photo from esmoopen.com

Elisa Agostinetto: The long and winding road to biomarkers for immunotherapy

Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on LinkedIn:

“The long and winding road to biomarkers for immunotherapy. A comprehensive analysis led by Laurence Buisseret of samples from patients with TNBC treated with pembrolizumab highlights the huge heterogeneity among TNBCs.

Now out in ESMO Open.”

No alternative text description for this image

Source: Elisa Agostinetto/LinkedIn

cancer Elisa Agostinetto ESMO Open immunotherapy Institute Jules Bordet Laurence Buisseret OncoDaily Oncology pembrolizumab